Is Bone Marrow Trephine Biopsy Necessary in Multiple Myeloma Patients at Diagnosis?

IF 2.7 4区 医学 Q2 HEMATOLOGY Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2024-12-07 DOI:10.1016/j.clml.2024.12.004
Ana Gea, Tatiana Fernández, Sara Fernández-Luis, Juan J Domínguez-García, Irene Francés, Ana Tobalina, Rodrigo Cantera, Julia Bannatyne, Irene Gorostidi, María Oviedo, Juan M Cerezo, Raquel García, Andrés Insunza, Carmen Montes-Gaisán, Aránzazu Bermúdez, Santiago Montes-Moreno, Montserrat Briz, Enrique M Ocio
{"title":"Is Bone Marrow Trephine Biopsy Necessary in Multiple Myeloma Patients at Diagnosis?","authors":"Ana Gea, Tatiana Fernández, Sara Fernández-Luis, Juan J Domínguez-García, Irene Francés, Ana Tobalina, Rodrigo Cantera, Julia Bannatyne, Irene Gorostidi, María Oviedo, Juan M Cerezo, Raquel García, Andrés Insunza, Carmen Montes-Gaisán, Aránzazu Bermúdez, Santiago Montes-Moreno, Montserrat Briz, Enrique M Ocio","doi":"10.1016/j.clml.2024.12.004","DOIUrl":null,"url":null,"abstract":"<p><p>Multiple myeloma (MM) diagnosis requires ≥10% plasma cell (PC) infiltration in the bone marrow (BM), detected by bone marrow aspiration (BMA) or biopsy (BMB). We evaluated the concordance of these 2 techniques in 189 patients. In 43 cases (23%), the techniques were discordant, 10 due to poor sample quality. In the remaining 33 patients, BMB diagnosed MM, while BMA detected < 10% PC, being symptomatic in 16 patients and smouldering (SMM) in 17. Without an initial BMB, 11% would have been misdiagnosed; and 12% of symptomatic patients would require a second BMA or BMB for strict diagnosis according to current criteria.</p>","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":" ","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2024-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Lymphoma, Myeloma & Leukemia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.clml.2024.12.004","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Multiple myeloma (MM) diagnosis requires ≥10% plasma cell (PC) infiltration in the bone marrow (BM), detected by bone marrow aspiration (BMA) or biopsy (BMB). We evaluated the concordance of these 2 techniques in 189 patients. In 43 cases (23%), the techniques were discordant, 10 due to poor sample quality. In the remaining 33 patients, BMB diagnosed MM, while BMA detected < 10% PC, being symptomatic in 16 patients and smouldering (SMM) in 17. Without an initial BMB, 11% would have been misdiagnosed; and 12% of symptomatic patients would require a second BMA or BMB for strict diagnosis according to current criteria.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
多发性骨髓瘤患者诊断时是否需要骨髓环钻活检?
多发性骨髓瘤(MM)的诊断需要骨髓(BM)浆细胞(PC)浸润≥10%,通过骨髓穿刺(BMA)或活检(BMB)检测。我们在189例患者中评估了这两种技术的一致性。在43例(23%)中,技术不一致,10例是由于样本质量差。在其余33例患者中,BMB诊断为MM, BMA检出< 10% PC, 16例有症状,17例有闷烧(SMM)。如果没有最初的BMB, 11%的人会被误诊;12%有症状的患者需要第二次BMA或BMB才能根据现行标准进行严格诊断。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.70
自引率
3.70%
发文量
1606
审稿时长
26 days
期刊介绍: Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed monthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma, myeloma and leukemia. Clinical Lymphoma, Myeloma & Leukemia is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia and related disorders including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias. The main emphasis is on recent scientific developments in all areas related to lymphoma, myeloma and leukemia. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.
期刊最新文献
Corrigendum to "Pharmacokinetics and Efficacy of Generic Melphalan is Comparable to Innovator Formulation in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplantation" [Clin Lymphoma Myeloma Leuk. 20/2 (2020) 130-135.e1]. Editorial Board Table of Contents Table of Contents Editorial Board
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1